Dr. Robert Kreitman explains how CD22-targeted CAR T could help heavily pretreated patients.
|Videos|May 8, 2017
200 Miles - One Patient's Journey for MMRF
Author(s)Tribeca Film Festival
Multiple myeloma advocate Eric Gelber makes history. Watch him as he makes his 200-mile journey.
Advertisement
200 Miles is the inspiring story of Chappaqua ultra-marathoner and multiple myeloma advocate, Eric Gelber, who made history by completing a record 200 miles around New York’s Central Park to raise awareness and $1 million for the Multiple Myeloma Research Foundation (MMRF).
Advertisement
Related to this article
Testicular cancer survivor Brian Sluga shares how faith, journaling and new goals, like training for marathons, helped him live a better life after cancer.
Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and stomach cancers. Here is what each found and what it means for patients.
An expert discusses infection risks after treatment, what follow-up care looks like and why patients with a rare cancer should ask questions, seek expert opinions and find community.
Median survival, hazard ratio, progression-free survival: a plain-language guide to the terms in cancer trial news, so you can tell what a result means for you and what to ask your care team.
Dr. Robert J. Kreitman explains how an experimental CAR T-cell therapy may help patients with relapsed hairy cell leukemia achieve lasting remissions.
Dr. Jacqueline Barrientos discussed how collaboration, individualized treatment and patient advocacy helped a 72-year-old man achieve leukemia remission and receive a kidney transplant.
Adding Imdelltra to Imfinzi maintenance helped people with extensive-stage small cell lung cancer live a median of 21.1 months vs. 12.7 months with Imfinzi alone in the phase 3 DeLLphi-305 trial.
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ESMO 2026 That Patients Should Know
2
What New KRAS Drug Data From ESMO 2026 Mean for Patients
3
What Liquid Biopsy and ESR1 Mutations Mean in Breast Cancer
4
Imdelltra Plus Imfinzi Extends Survival in Small Cell Lung Cancer
5